Repligen | RGEN - Kewajiban Lancar





Kewajiban Lancar Perubahan Tanggal
Agilent USD 2.27B 35M 2026-03
Align Technology USD 1.91B 2.74M 2026-06
Bio Techne USD 153.28M 12.85M 2026-03
BioMarin Pharmaceutical USD 1.66B 870.84M 2026-06
Bristol-Myers Squibb USD 18.66B 499M 2026-06
Bruker USD 1.2B 150.4M 2026-06
Charles River Laboratories USD 1.13B 41.04M 2026-06
Danaher USD 8.1B 645M 2026-06
Dentsply International USD 1.18B 22M 2026-06
General Electric Aerospace USD 40.43B 403M 2026-06
Henry Schein USD 3.49B 191M 2026-06
Illumina USD 1.58B 12M 2026-06
IQVIA Holdings USD 8.82B 486M 2026-06
Mettler Toledo International USD 1.2B 92.14M 2026-06
Myriad Genetics USD 130.7M 500K 2026-06
OraSure Technologies USD 25.12M 18.96M 2026-06
Pacific Biosciences Of California USD 68.81M 3.45M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Repligen USD 132.66M 6.45M 2026-06
Revvity USD 1.28B 37.71M 2026-06
Standard Biotools USD 42.2M 66.1M 2026-03
Thermo Fisher Scientific USD 15.07B 448M 2026-06
Waters USD 2.27B 1.03B 2026-03
West Pharmaceutical Services USD 640.5M 33.5M 2026-06